Glucagon-like peptide agonists: A prospective review.

Published in: Endocrinology, diabetes & metabolism (2023)

In conclusion, this review underscores the significance of GLP-1RAs, with a specific focus on semaglutide, in the management of type 2 diabetes, obesity, and beyond. By synthesizing information on their mechanisms, pharmacokinetics, efficacy, and safety, this review provides valuable insights into the potential benefits these agents offer, contributing to the ongoing discourse in the field.

Keyphrases

metabolic syndrome
type diabetes
healthcare
climate change
risk assessment
adipose tissue
skeletal muscle
high fat diet induced